Skip to main content

Can we predict and prevent adult morbidity in males with childhood‐onset growth hormone deficiency?

Buy Article:

$43.00 plus tax (Refund Policy)

In order to achieve an optimal quality of life and minimize morbidity in adulthood, the therapeutic management of patients with childhood‐onset growth hormone deficiency (GHD) should follow strict guidelines. Optimal final height should be obtained by the early diagnosis of GHD and subsequent adequate growth hormone (GH) dosing and duration of treatment. Moreover, particularly in males with associated gonadotrophin deficiency, the psychosexual maladjustment could be prevented by the earlier induction of puberty, completion of the male phenotype and testicular stimulation with gonadotropins or luteinizing hormone‐releasing hormone. Finally, a satisfactory peak bone mass could be attained by continuation of GH treatment for some years after cessation of linear growth. □ Childhood‐onset growth hormone deficiency, pubertal induction, quality of life, optimal peak bone mass
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Document Type: Short Communication

Publication date: 1997-11-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more